Sanofi Collaborates with Oncodesign to Develop Inhibitors of Challenging Kinase Targets
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 9 (Table of Contents)
Published: 26 Sep-2012
DOI: 10.3833/pdr.v2012.i9.1808 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Oncodesign has entered into its second deal of 2012, this time a 4-year strategic research collaboration with Sanofi, potentially worth up to €130 M (US$167 M), to apply its Nanocyclix® medicinal chemistry technology and research platform in multiple Sanofi kinase programmes...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS